GGrantIndex
Sort

10,829 grants matching car t

MSKCC BMT CTN Renewal

$197,052
Miguel-Angel Perales · Sloan-Kettering Inst Can Research · UG1 · FY2022 · HL

Development of A Novel Imaging Strategy for Evaluation of CAR T-Cell Therapy in Glioblastoma

$197,036
Corinne Beinat · Stanford University · R21 · FY2022 · NS

KIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function

$196,934
Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA

Trial to Examine Text Message-based mHealth in Emergency department patients with Diabetes with Family And friends Network Supporters (TExT-MED+FANS)

$196,880
Elizabeth Rhea Erwin Burner · University Of Southern California · K23 · FY2017 · DK

In vivo CAR-T-cell HIV therapy using in vitro reconstituted virus-like particles

$196,875
William M Gelbart · University Of California Los Angeles · R21 · FY2024 · AI

Middle Ear Epithelial Response to Cytokine Stimulation

$196,766
Medical College Of Wisconsin · K08 · FY2005 · DC

mZap! A mobile, community-based GPS mapping surveillance tool empowering communities to alleviate insect-borne disease and ecological risk in Costa Rica

$196,752
Timothy D Dye · University Of Rochester · R21 · FY2018 · TW

IDENTIFICATION & FUNCTIONAL CHARACTERIZATION OF SNPS IN RXRA GENE

$196,694
Xiao-Bo Zhong · University Of Kansas Medical Center · P20 · FY2009 · RR

Randomized Evaluation of a Community College Intervention Designed to Increase Persistence and Completion

$196,670
James Sullivan · University Of Notre Dame · R21 · FY2016 · HD

R21-UKY East Palestine Train Derailment Health Tracking Study

$196,666
Erin N Haynes · University Of Kentucky · R21 · FY2025 · ES

CAR mast cell for solid tumor

$196,646
Xiaolei Su · Yale University · R21 · FY2025 · CA

Enhancing Early-Phase Care for Primary Care Patients with Unhealthy Substance Use

$196,609
Elizabeth L Merrick · Brandeis University · R21 · FY2012 · DA

Optimizing mobile behavioral economic interventions for rural risky drinkers

$196,560
Lara Nicole Coughlin · University Of Michigan At Ann Arbor · K23 · FY2022 · AA

Optimizing mobile behavioral economic interventions for rural risky drinkers

$196,560
Lara Nicole Coughlin · University Of Michigan At Ann Arbor · K23 · FY2021 · AA

Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell Therapy

$196,560
Sara Barmettler · Massachusetts General Hospital · K23 · FY2022 · AI

Optimizing mobile behavioral economic interventions for rural risky drinkers

$196,560
Lara Nicole Coughlin · University Of Michigan At Ann Arbor · K23 · FY2020 · AA

Middle Ear Epithelial Response to Cytokine Stimulation

$196,501
Medical College Of Wisconsin · K08 · FY2004 · DC

Emotion Dysregulation and Risky Behavior Among People Who Inject Drugs

$196,364
Mary Ellen Mackesy-Amiti · University Of Illinois At Chicago · R21 · FY2016 · DA

Development of a text messaging tool to support buprenorphine treatment in primary care

$196,271
Babak Tofighi · New York University School Of Medicine · K23 · FY2020 · DA

New innovations: advancing mast cell biology

$196,250
Mark Christopher Siracusa · Rutgers Biomedical And Health Sciences · R21 · FY2023 · AI

Statistical Learning for High-Dimensional Stochastic Dynamical Systems

$196,236
Mauro Maggioni · Duke University · · FY2015 · MPS

Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL

$196,110
Lisa Madalen Niswander · Roswell Park Cancer Institute Corp · K08 · FY2025 · CA

Middle Ear Epithelial Response to Cytokine Stimulation

$196,004
Medical College Of Wisconsin · K08 · FY2003 · DC

Engineering CAR-T for treatment of alcoholic liver disease

$195,938
Douglas Edmund Feldman · University Of Southern California · R21 · FY2019 · AA

An adaptive treatment intervention for depression and engagement in HIV care among Latinos living with HIV

$195,779
John Andrew Sauceda · University Of California, San Francisco · K01 · FY2017 · MH